Dyne Therapeutics, Inc. Other Executive Compensation Disclosures
Every other executive-compensation XBRL fact the company filed (policies, award timing, footnotes, adjustments), newest first. Long text is shortened; the filing has the full text.
- 2026-07-29: Disclosure Rule10b51Arr Adopted; Period 2026-04-01..2026-06-30; Value No.
- 2026-07-29: Disclosure Rule10b51Arr Terminated; Period 2026-04-01..2026-06-30; Value No.
- 2026-07-29: Disclosure Non Rule10b51Arr Adopted; Period 2026-04-01..2026-06-30; Value No.
- 2026-07-29: Disclosure Non Rule10b51Arr Terminated; Period 2026-04-01..2026-06-30; Value No.
| Filed | Disclosure | Qualifiers | Period | Value |
|---|---|---|---|---|
| 2026-07-29 10-Q | Rule10b51Arr Adopted | 2026-04-01..2026-06-30 | No | |
| 2026-07-29 10-Q | Rule10b51Arr Terminated | 2026-04-01..2026-06-30 | No | |
| 2026-07-29 10-Q | Non Rule10b51Arr Adopted | 2026-04-01..2026-06-30 | No | |
| 2026-07-29 10-Q | Non Rule10b51Arr Terminated | 2026-04-01..2026-06-30 | No | |
| 2026-05-11 10-Q | Material Terms Of Trading Arrangement | 2026-01-01..2026-03-31 | Item 5. Other Information. Director and Officer Trading Arrangements The following table describes, for the period covered by this Quarterly Report, each trading arrangement for the sale or purchase of Company securities adopted or terminated by our directors and officers that is a contract, instruc… | |
| 2026-05-11 10-Q | Rule10b51Arr Adopted | 2026-01-01..2026-03-31 | No | |
| 2026-05-11 10-Q | Non Rule10b51Arr Adopted | 2026-01-01..2026-03-31 | No | |
| 2026-05-11 10-Q | Rule10b51Arr Terminated | 2026-01-01..2026-03-31 | No | |
| 2026-05-11 10-Q | Non Rule10b51Arr Terminated | 2026-01-01..2026-03-31 | No | |
| 2026-04-23 DEF 14A | Insider Trading Policies Proc Adopted | 2025-01-01..2025-12-31 | Yes | |
| 2026-04-23 DEF 14A | Award Timing MNPI Disclosure | 2025-01-01..2025-12-31 | Policies and Practices Related to the Grant of Equity Awards The Company does not have any formal policies regarding the timing of awards of options in relation to the disclosure of material nonpublic information by the Company. We grant equity awards, including stock options and RSUs, to our employ… | |
| 2026-04-23 DEF 14A | Award Timing MNPI Considered | 2025-01-01..2025-12-31 | No | |
| 2026-04-23 DEF 14A | Award Timing Method | 2025-01-01..2025-12-31 | We grant equity awards, including stock options and RSUs, to our employees and directors on an annual basis. The Company’s historical practice through 2024 was to make annual grants of equity awards, including options and RSUs, in the fourth quarter of each year , following the release of the Compan… | |
| 2026-04-23 DEF 14A | Award Timing Predetermined | 2025-01-01..2025-12-31 | Yes | |
| 2026-04-23 DEF 14A | MNPI Disclosure Timed For Compensation Val | 2025-01-01..2025-12-31 | No | |
| 2026-04-23 DEF 14A | Pay versus Performance Table | 2025-01-01..2025-12-31 | P ay Versus Performance The following tables and related disclosures provide information about (i) the “total compensation” of our principal executive officers, or PEOs, and our other named executive officers, or Other NEOs, as presented in the Summary Compensation Table on page 36 , or the SCT Amou… | |
| 2026-04-23 DEF 14A | PEO Total Compensation | Individual: CoxJohnG | 2025-01-01..2025-12-31 | $2.08M |
| 2026-04-23 DEF 14A | PEO Actually Paid Compensation | Individual: CoxJohnG | 2025-01-01..2025-12-31 | -$1.77M |
| 2026-04-23 DEF 14A | PEO Total Compensation | Individual: BrummJosh | 2025-01-01..2025-12-31 | $0.00 |
| 2026-04-23 DEF 14A | PEO Actually Paid Compensation | Individual: BrummJosh | 2025-01-01..2025-12-31 | $0.00 |
| 2026-04-23 DEF 14A | PEO Total Compensation | Individual: CoxJohnG | 2024-01-01..2024-12-31 | $20.69M |
| 2026-04-23 DEF 14A | PEO Actually Paid Compensation | Individual: CoxJohnG | 2024-01-01..2024-12-31 | $17.01M |
| 2026-04-23 DEF 14A | PEO Total Compensation | Individual: BrummJosh | 2024-01-01..2024-12-31 | $14.38M |
| 2026-04-23 DEF 14A | PEO Actually Paid Compensation | Individual: BrummJosh | 2024-01-01..2024-12-31 | $9.76M |
| 2026-04-23 DEF 14A | PEO Total Compensation | Individual: CoxJohnG | 2023-01-01..2023-12-31 | $0.00 |
| 2026-04-23 DEF 14A | PEO Actually Paid Compensation | Individual: CoxJohnG | 2023-01-01..2023-12-31 | $0.00 |
| 2026-04-23 DEF 14A | PEO Total Compensation | Individual: BrummJosh | 2023-01-01..2023-12-31 | $5.97M |
| 2026-04-23 DEF 14A | PEO Actually Paid Compensation | Individual: BrummJosh | 2023-01-01..2023-12-31 | $7.48M |
| 2026-04-23 DEF 14A | PEO Total Compensation | Individual: CoxJohnG | 2022-01-01..2022-12-31 | $0.00 |
| 2026-04-23 DEF 14A | PEO Actually Paid Compensation | Individual: CoxJohnG | 2022-01-01..2022-12-31 | $0.00 |
| 2026-04-23 DEF 14A | PEO Total Compensation | Individual: BrummJosh | 2022-01-01..2022-12-31 | $4.32M |
| 2026-04-23 DEF 14A | PEO Actually Paid Compensation | Individual: BrummJosh | 2022-01-01..2022-12-31 | $2.46M |
| 2026-04-23 DEF 14A | Named Executive Officers Footnote | 2025-01-01..2025-12-31 | (1) For 2025, the PEO was John G. Cox , and the Other NEOs were Erick Lucera, Johanna Friedl-Naderer, Douglas Kerr, Richard Scalzo, and Oxana Beskrovnaya. For 2024, the first PEO was Josh Brumm , the second PEO was John G. Cox , and the Other NEOs were Richard Scalzo, Oxana Beskrovnaya, Johanna Frie… | |
| 2026-04-23 DEF 14A | PEO Name | Individual: CoxJohnG | 2025-01-01..2025-12-31 | John G. Cox |
| 2026-04-23 DEF 14A | PEO Name | Individual: BrummJosh | 2024-01-01..2024-12-31 | Josh Brumm |
| 2026-04-23 DEF 14A | PEO Name | Individual: CoxJohnG | 2024-01-01..2024-12-31 | John G. Cox |
| 2026-04-23 DEF 14A | PEO Name | Individual: BrummJosh | 2023-01-01..2023-12-31 | Josh Brum |
| 2026-04-23 DEF 14A | PEO Name | Individual: BrummJosh | 2022-01-01..2022-12-31 | Josh Brumm |
| 2026-04-23 DEF 14A | Adjustment To PEO Compensation Footnote | 2025-01-01..2025-12-31 | (3) The peer group used for this purpose is the Nasdaq Biotechnology Index. Adjustments 2025 2024 2023 2022 Cox, John G. Other NEOs* Cox, John G. Brumm, Josh Other NEOs* Cox, John G. Brumm, Josh Other NEOs* Cox, John G. Brumm, Josh Other NEOs* Summary Compensation Table (SCT) Total $ 2,076,868 $ 1,3… | |
| 2026-04-23 DEF 14A | Adjustment To Non PEO NEO Compensation Footnote | 2025-01-01..2025-12-31 | (3) The peer group used for this purpose is the Nasdaq Biotechnology Index. Adjustments 2025 2024 2023 2022 Cox, John G. Other NEOs* Cox, John G. Brumm, Josh Other NEOs* Cox, John G. Brumm, Josh Other NEOs* Cox, John G. Brumm, Josh Other NEOs* Summary Compensation Table (SCT) Total $ 2,076,868 $ 1,3… | |
| 2026-04-23 DEF 14A | Peer Group Issuers Footnote | 2025-01-01..2025-12-31 | (3) The peer group used for this purpose is the Nasdaq Biotechnology Index. | |
| 2026-04-23 DEF 14A | PEO Total Compensation | Individual: OtherNEOs | 2025-01-01..2025-12-31 | $1.31M |
| 2026-04-23 DEF 14A | PEO Total Compensation | Individual: OtherNEOs | 2024-01-01..2024-12-31 | $5.56M |
| 2026-04-23 DEF 14A | PEO Total Compensation | Individual: OtherNEOs | 2023-01-01..2023-12-31 | $2.14M |
| 2026-04-23 DEF 14A | PEO Total Compensation | Individual: OtherNEOs | 2022-01-01..2022-12-31 | $1.54M |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsInSummryCompstnTblForAplblYr; ExecutiveCategory: Peo; Individual: CoxJohnG | 2025-01-01..2025-12-31 | -$937.89K |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsInSummryCompstnTblForAplblYr; ExecutiveCategory: NonPeoNeo; Individual: OtherNEOs | 2025-01-01..2025-12-31 | -$635.62K |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsInSummryCompstnTblForAplblYr; ExecutiveCategory: Peo; Individual: CoxJohnG | 2024-01-01..2024-12-31 | -$19.81M |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsInSummryCompstnTblForAplblYr; ExecutiveCategory: Peo; Individual: BrummJosh | 2024-01-01..2024-12-31 | -$13.70M |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsInSummryCompstnTblForAplblYr; ExecutiveCategory: NonPeoNeo; Individual: OtherNEOs | 2024-01-01..2024-12-31 | -$5.05M |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsInSummryCompstnTblForAplblYr; ExecutiveCategory: Peo; Individual: CoxJohnG | 2023-01-01..2023-12-31 | $0.00 |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsInSummryCompstnTblForAplblYr; ExecutiveCategory: Peo; Individual: BrummJosh | 2023-01-01..2023-12-31 | -$4.87M |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsInSummryCompstnTblForAplblYr; ExecutiveCategory: NonPeoNeo; Individual: OtherNEOs | 2023-01-01..2023-12-31 | -$1.43M |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsInSummryCompstnTblForAplblYr; ExecutiveCategory: Peo; Individual: CoxJohnG | 2022-01-01..2022-12-31 | $0.00 |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsInSummryCompstnTblForAplblYr; ExecutiveCategory: Peo; Individual: BrummJosh | 2022-01-01..2022-12-31 | -$3.37M |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsInSummryCompstnTblForAplblYr; ExecutiveCategory: NonPeoNeo; Individual: OtherNEOs | 2022-01-01..2022-12-31 | -$897.05K |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstd; ExecutiveCategory: Peo; Individual: CoxJohnG | 2025-01-01..2025-12-31 | $2.79M |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstd; ExecutiveCategory: NonPeoNeo; Individual: OtherNEOs | 2025-01-01..2025-12-31 | $1.35M |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstd; ExecutiveCategory: Peo; Individual: CoxJohnG | 2024-01-01..2024-12-31 | $16.13M |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstd; ExecutiveCategory: Peo; Individual: BrummJosh | 2024-01-01..2024-12-31 | $0.00 |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstd; ExecutiveCategory: NonPeoNeo; Individual: OtherNEOs | 2024-01-01..2024-12-31 | $3.69M |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstd; ExecutiveCategory: Peo; Individual: CoxJohnG | 2023-01-01..2023-12-31 | $0.00 |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstd; ExecutiveCategory: Peo; Individual: BrummJosh | 2023-01-01..2023-12-31 | $5.98M |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstd; ExecutiveCategory: NonPeoNeo; Individual: OtherNEOs | 2023-01-01..2023-12-31 | $1.73M |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstd; ExecutiveCategory: Peo; Individual: CoxJohnG | 2022-01-01..2022-12-31 | $0.00 |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstd; ExecutiveCategory: Peo; Individual: BrummJosh | 2022-01-01..2022-12-31 | $3.34M |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstd; ExecutiveCategory: NonPeoNeo; Individual: OtherNEOs | 2022-01-01..2022-12-31 | $982.94K |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrs; ExecutiveCategory: Peo; Individual: CoxJohnG | 2025-01-01..2025-12-31 | -$2.50M |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrs; ExecutiveCategory: NonPeoNeo; Individual: OtherNEOs | 2025-01-01..2025-12-31 | -$479.62K |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrs; ExecutiveCategory: Peo; Individual: CoxJohnG | 2024-01-01..2024-12-31 | $0.00 |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrs; ExecutiveCategory: Peo; Individual: BrummJosh | 2024-01-01..2024-12-31 | $3.41M |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrs; ExecutiveCategory: NonPeoNeo; Individual: OtherNEOs | 2024-01-01..2024-12-31 | $826.08K |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrs; ExecutiveCategory: Peo; Individual: CoxJohnG | 2023-01-01..2023-12-31 | $0.00 |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrs; ExecutiveCategory: Peo; Individual: BrummJosh | 2023-01-01..2023-12-31 | $794.89K |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrs; ExecutiveCategory: NonPeoNeo; Individual: OtherNEOs | 2023-01-01..2023-12-31 | $234.00K |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrs; ExecutiveCategory: Peo; Individual: CoxJohnG | 2022-01-01..2022-12-31 | $0.00 |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrs; ExecutiveCategory: Peo; Individual: BrummJosh | 2022-01-01..2022-12-31 | -$287.26K |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrs; ExecutiveCategory: NonPeoNeo; Individual: OtherNEOs | 2022-01-01..2022-12-31 | -$102.95K |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYr; ExecutiveCategory: Peo; Individual: CoxJohnG | 2025-01-01..2025-12-31 | $0.00 |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYr; ExecutiveCategory: NonPeoNeo; Individual: OtherNEOs | 2025-01-01..2025-12-31 | $0.00 |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYr; ExecutiveCategory: Peo; Individual: CoxJohnG | 2024-01-01..2024-12-31 | $0.00 |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYr; ExecutiveCategory: Peo; Individual: BrummJosh | 2024-01-01..2024-12-31 | $0.00 |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYr; ExecutiveCategory: NonPeoNeo; Individual: OtherNEOs | 2024-01-01..2024-12-31 | $0.00 |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYr; ExecutiveCategory: Peo; Individual: CoxJohnG | 2023-01-01..2023-12-31 | $0.00 |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYr; ExecutiveCategory: Peo; Individual: BrummJosh | 2023-01-01..2023-12-31 | $24.38K |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYr; ExecutiveCategory: NonPeoNeo; Individual: OtherNEOs | 2023-01-01..2023-12-31 | $17.72K |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYr; ExecutiveCategory: Peo; Individual: CoxJohnG | 2022-01-01..2022-12-31 | $0.00 |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYr; ExecutiveCategory: Peo; Individual: BrummJosh | 2022-01-01..2022-12-31 | $0.00 |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYr; ExecutiveCategory: NonPeoNeo; Individual: OtherNEOs | 2022-01-01..2022-12-31 | $0.00 |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYr; ExecutiveCategory: Peo; Individual: CoxJohnG | 2025-01-01..2025-12-31 | -$3.19M |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYr; ExecutiveCategory: NonPeoNeo; Individual: OtherNEOs | 2025-01-01..2025-12-31 | -$676.78K |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYr; ExecutiveCategory: Peo; Individual: CoxJohnG | 2024-01-01..2024-12-31 | $0.00 |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYr; ExecutiveCategory: Peo; Individual: BrummJosh | 2024-01-01..2024-12-31 | $7.60M |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYr; ExecutiveCategory: NonPeoNeo; Individual: OtherNEOs | 2024-01-01..2024-12-31 | $989.05K |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYr; ExecutiveCategory: Peo; Individual: CoxJohnG | 2023-01-01..2023-12-31 | $0.00 |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYr; ExecutiveCategory: Peo; Individual: BrummJosh | 2023-01-01..2023-12-31 | -$429.61K |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYr; ExecutiveCategory: NonPeoNeo; Individual: OtherNEOs | 2023-01-01..2023-12-31 | -$53.71K |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYr; ExecutiveCategory: Peo; Individual: CoxJohnG | 2022-01-01..2022-12-31 | $0.00 |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYr; ExecutiveCategory: Peo; Individual: BrummJosh | 2022-01-01..2022-12-31 | -$1.54M |
| 2026-04-23 DEF 14A | Adjustment To Compensation | AdjToComp: FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYr; ExecutiveCategory: NonPeoNeo; Individual: OtherNEOs | 2022-01-01..2022-12-31 | -$383.24K |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arcus Biosciences, Inc. (RCUS) | United States | $3.188B | -8.52 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| PRECIGEN, INC. (PGEN) | United States | $2.757B | -12.94 |
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |